Duopharma Biotech Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	268.67	264.55	270.5	157.64	137.98	158.03
Cash & Short-Term Investments	268.67	264.55	270.5	157.64	137.98	158.03
Cash Growth	3.17%	-2.20%	71.60%	14.25%	-12.69%	30.96%
Accounts Receivable	231.13	184.33	135.04	131.31	122.42	112.99
Other Receivables	16.84	23.59	26.38	10.84	10.31	22.18
Receivables	247.97	207.92	161.42	142.15	132.72	135.17
Inventory	294.41	248.55	243.07	235.18	222.19	151.27
Prepaid Expenses	-	5.39	2.08	6.52	1.9	0.67
Other Current Assets	-	-	-	-	-	14.56
Total Current Assets	811.05	726.4	677.07	541.49	494.8	459.69
Property, Plant & Equipment	559.77	567.52	582.37	579.92	542.53	441.79
Long-Term Investments	22.16	22.67	36.91	42.15	73.54	112.25
Other Intangible Assets	40.65	7.32	7.65	3.84	4.95	4.66
Long-Term Deferred Tax Assets	16.16	15.33	8.95	13.33	12.7	8.54
Long-Term Deferred Charges	-	37.55	31.15	40.14	34.58	30.41
Other Long-Term Assets	1.05	1.05	1.05	1.05	1.05	1.1
Total Assets	1,451	1,378	1,345	1,222	1,164	1,058
Accounts Payable	174.47	55.89	40.45	51.93	31.32	28.15
Accrued Expenses	-	46.92	33.79	40.46	61.2	45.62
Short-Term Debt	-	32.33	50.59	101.8	87.85	36.11
Current Portion of Long-Term Debt	141.18	15.66	14.95	32.34	15.08	12.68
Current Portion of Leases	-	0.55	0.92	0.94	0.64	0.6
Current Income Taxes Payable	3.78	0.74	0.37	1.17	6.06	0.74
Other Current Liabilities	-	25.89	25.65	35.95	28.17	26.41
Total Current Liabilities	319.43	177.99	166.73	264.59	230.31	150.32
Long-Term Debt	349.82	464.52	480.9	294.6	297.8	253.28
Long-Term Leases	2.79	2.76	1.48	1.92	2.48	0.66
Long-Term Deferred Tax Liabilities	34.69	23.42	8.91	5.58	9.54	10.35
Total Liabilities	706.72	668.68	658.01	566.7	540.13	414.61
Common Stock	432.47	432.47	432.47	419.37	405.86	404.92
Retained Earnings	389.52	354.78	319.07	288.37	239.97	220.18
Comprehensive Income & Other	-77.87	-78.09	-64.41	-52.52	-21.82	18.72
Shareholders' Equity	744.12	709.15	687.12	655.22	624	643.82
Total Liabilities & Equity	1,451	1,378	1,345	1,222	1,164	1,058
Total Debt	493.78	515.82	548.85	431.6	403.84	303.33
Net Cash (Debt)	-225.12	-251.28	-278.35	-273.97	-265.86	-145.31
Net Cash Per Share	-0.23	-0.26	-0.29	-0.29	-0.29	-0.16
Filing Date Shares Outstanding	961.94	961.94	961.94	952.24	941.77	941.37
Total Common Shares Outstanding	961.94	961.94	961.94	952.24	941.77	941.37
Working Capital	491.62	548.42	510.34	276.9	264.49	309.37
Book Value Per Share	0.77	0.74	0.71	0.69	0.66	0.68
Tangible Book Value	703.47	701.84	679.47	651.38	619.06	639.16
Tangible Book Value Per Share	0.73	0.73	0.71	0.68	0.66	0.68
Land	-	65.68	65.68	69.88	69.88	69.88
Buildings	-	267.09	265.86	125.23	124.51	119.57
Machinery	-	452.39	435.18	368.47	308.94	291.64
Construction In Progress	-	12.19	8.48	172.65	162.63	65.81

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.